Incyte Corporation continues to beat expectations with strong revenue growth and margin expansion. Read why INCY stock is a ...

To soften the blow, CSPC has accelerated its shift from generic drugs to innovative medicines. In the first three quarters, ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

Pharmacy benefit managers (PBMs) are back in the crosshairs. PBMs negotiate drug prices down on behalf of consumers and insurers – to the ire of ...

The discounts should be compared against the drugs’ “ultimate net price” rather than their indicated list price to gauge the ...

As experts warn that flu season may start earlier this year, they say over-the-counter generic drugs may offer the same benefits as brand names at a fraction of the cost.

U.S. District Judge Cynthia Rufe, of the Eastern District of Pennsylvania, gave the claims recovery firms seven days to provide lead counsel with a list of names and contact information for all class ...

The Ministry of Health, Labour and Welfare ("the MHLW") currently lacks sufficient legal experience to assess whether a generic product will, ...

73% lower for Trelegy Ellipta, which treats asthma and chronic obstructive pulmonary disease (COPD) and was taken by 1.3 million Medicare Part D enrollees last year. 60% lower for Pomalyst, which ...

On Tuesday, November 25, the Centers for Medicare & Medicaid Services (CMS) announced that it will reduce the cost of 15 prescription drugs for Medicare users in 2027. This cut is expected to save ...

The second round of negotiations cuts spending an aggregate 44% over 2024 list prices as the federal government extends ...

Unequal global access to inflammatory bowel disease (IBD) therapies creates profound health inequities. The increasing prevalence of IBD in Western countries, driven by high incidence rates and low ...